When lithium or valproate aren't enough, ‘add-on’ treatments like atypical antipsychotics can help. Discover 7 options to discuss with your doctor.

Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved ...

About 1 in 4 people suffer from an anxiety disorder at some point in their lives. These include panic disorder with sudden, severe anxiety attacks; generalized anxiety disorder, in which sufferers ...

Vanda Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved BYSANTItm (milsaperidone) tablets, a first line therapy for the acute treatment of manic or ...

GLP-1 therapy may lower CKD dementia risk and Alzheimer’s incidence in diabetic patients. Explore the latest evidence and clinical implications.

People using weight-loss injections are being urged to stay alert of serious pancreas conditions Get the Well Enough newsletter with Harry Bullmore for tips on living a healthier, happier and longer ...

Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved BYSANTI ...

Issued on behalf of Helus PharmaVANCOUVER, BC, Feb. 27, 2026 /CNW/ -- Equity-Insider.com News Commentary -- Psychedelic compounds are edging closer to ...

Neurological autoimmune diseases happen when the immune system attacks the central nervous system (CNS) or peripheral nervous system (PNS). This can cause neurological symptoms, and about 30 ...